Saama is a healthcare and life-sciences technology company that provides an AI-backed SaaS platform for clinical development and commercialization. Founded in 1997, the firm applies data science to the drug-development process, turning complex clinical data into actionable insights for pharmaceutical, biotechnology and clinical-research organisations. Its stated aim is to automate manual workflows and accelerate the delivery of therapies to patients.
The company's product portfolio spans the clinical data lifecycle. Data Hub supports clinical development data management; Smart Data Quality addresses clinical data quality; Operational Insights provides visibility into clinical-trial operations; and Patient Insights delivers analytics on patient-related clinical data. Saama also offers statistical programming and regulatory submission tools, alongside an AI-powered document generator built on generative AI.
Engineering work at Saama spans artificial intelligence, machine learning, advanced analytics, generative AI and agentic AI, as well as clinical analytics, data platform implementation and modernisation, and managed services. Domain expertise in life sciences and pharmaceuticals underpins the platform, which is applied to data-intensive processes across drug development.
The company operates in the United States, India, the United Kingdom, Switzerland, Poland and Canada, serving the life-sciences, healthcare, pharmaceuticals and clinical-research sectors.
